{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T02:28:57Z","timestamp":1786328937815,"version":"build-2736575974"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"DOI":"10.1186\/s12969-026-01228-1","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T09:46:10Z","timestamp":1780566370000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Breaking the storm: canakinumab as salvage therapy for refractory macrophage activation syndrome in pediatric systemic lupus erythematosus\u2014a case report"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2086-6752","authenticated-orcid":false,"given":"Tarun","family":"Selvarajan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0089-1832","authenticated-orcid":false,"given":"Lavanya","family":"Kannekanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0202-4077","authenticated-orcid":false,"given":"Ashlyn","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra Zamora","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarwat","family":"Umer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"issue":"4","key":"1228_CR1","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.jpeds.2007.09.019","volume":"152","author":"LT Hiraki","year":"2008","unstructured":"Hiraki LT, Benseler SM, Tyrrell PN, Hebert D, Harvey E, Silverman ED. Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study. J Pediatr. 2008;152(4):550\u20136.","journal-title":"J Pediatr"},{"issue":"2","key":"1228_CR2","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1002\/art.23204","volume":"58","author":"HI Brunner","year":"2008","unstructured":"Brunner HI, Gladman DD, Ib\u00e1\u00f1ez D, Urowitz MD, Silverman ED. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum. 2008;58(2):556\u201362.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"1228_CR3","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1177\/0961203319854139","volume":"28","author":"ED Batu","year":"2019","unstructured":"Batu ED, S\u00f6nmez HE, Ta\u015fk\u0131ran E, Bilginer Y, \u00d6zen S. Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study. Lupus. 2019;28(8):1017\u201326.","journal-title":"Lupus"},{"issue":"3","key":"1228_CR4","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/art.39332","volume":"68","author":"A Ravelli","year":"2016","unstructured":"Ravelli A, Minoia F, Dav\u00ec S, Horne A, Bovis F, Pistorio A, et al. 2016 Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International Trials Organisation collaborative initiative. Arthritis Rheumatol. 2016;68(3):566\u201376.","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"1228_CR5","first-page":"359","volume":"46","author":"D Caparros-Ruiz","year":"2016","unstructured":"Caparros-Ruiz D, Ruiz-Antor\u00e1n B, Labrador-Horrillo M, Isenberg DA. Management of macrophage activation syndrome in systemic lupus erythematosus: A systematic review. Semin Arthritis Rheum. 2016;46(3):359\u201370.","journal-title":"Semin Arthritis Rheum"},{"key":"1228_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3389\/fimmu.2019.00119","volume":"10","author":"CB Crayne","year":"2019","unstructured":"Crayne CB, Albeituni S, Nichols KE, Cron RQ. The immunology of macrophage activation syndrome. Front Immunol. 2019;10:119.","journal-title":"Front Immunol"},{"issue":"1","key":"1228_CR7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/rheumatology\/keae391","volume":"64","author":"F Baldo","year":"2025","unstructured":"Baldo F, Erkens RGA, Mizuta M, Rogani G, Lucioni F, Bracaglia C, et al. PReS MAS\/sJIA Working Party and Paediatric Rheumatology International Trial Organization. Current treatment in macrophage activation syndrome worldwide: a systematic literature review to inform the METAPHOR project. Rheumatology (Oxford). 2025;64(1):32\u201344. https:\/\/doi.org\/10.1093\/rheumatology\/keae391.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"1228_CR8","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/art.41103","volume":"72","author":"EM Eloseily","year":"2020","unstructured":"Eloseily EM, Weiser P, Crayne CB, Haines H, Mannion ML, Stoll ML, et al. Benefit of anakinra in treating pediatric secondary hemophagocytic lymphohistiocytosis. Arthritis Rheumatol. 2020;72(2):326\u201334.","journal-title":"Arthritis Rheumatol"},{"key":"1228_CR9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12969-020-00450-9","volume":"18","author":"R Papa","year":"2020","unstructured":"Papa R, Natoli V, Caorsi R, Minoia F, Gattorno M, Ravelli A. Successful treatment of refractory hyperferritinemic syndromes with canakinumab: a report of two cases. Pediatr Rheumatol Online J. 2020;18:56. https:\/\/doi.org\/10.1186\/s12969-020-00450-9.","journal-title":"Pediatr Rheumatol Online J"},{"key":"1228_CR10","doi-asserted-by":"publisher","first-page":"894846","DOI":"10.3389\/fped.2022.894846","volume":"10","author":"MM Kostik","year":"2022","unstructured":"Kostik MM, Isupova EA, Belozerov K, Likhacheva TS, Suspitsin EN, Raupov R, et al. Standard and increased canakinumab dosing to quiet macrophage activation syndrome in children with systemic juvenile idiopathic arthritis. Front Pediatr. 2022;10:894846. https:\/\/doi.org\/10.3389\/fped.2022.894846.","journal-title":"Front Pediatr"},{"issue":"9","key":"1228_CR11","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/art.40930","volume":"71","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019;71(9):1400\u201312.","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"1228_CR12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Aric\u00f2 M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124\u201331.","journal-title":"Pediatr Blood Cancer"},{"key":"1228_CR13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12969-021-00585-3","volume":"19","author":"O Phadke","year":"2021","unstructured":"Phadke O, Rouster-Stevens K, Giannopoulos H, Chandrakasan S, Prahalad S. Intravenous administration of anakinra in children with macrophage activation syndrome. Pediatr Rheumatol Online J. 2021;19:98. https:\/\/doi.org\/10.1186\/s12969-021-00585-3.","journal-title":"Pediatr Rheumatol Online J"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-026-01228-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-026-01228-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-026-01228-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T01:52:32Z","timestamp":1786326752000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12969-026-01228-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1228"],"URL":"https:\/\/doi.org\/10.1186\/s12969-026-01228-1","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]},"assertion":[{"value":"13 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This case report was conducted in accordance with institutional ethical standards. Written informed consent was not required as no identifiable patient information was included.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patient identifying information has been de-identified per institutional policy to protect patient privacy.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"51"}}